ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Updates

SUB-TYPE: CLASS 4 CAUTION IN USE

CLASS 4 CAUTION IN USE - NAPROSYN TABLETS (ALL STRENGTHS), NAPROSYN EC 500MG GASTRO-RESISTANT TABLETS

Additional to the batches included in the previous Class 4 Medicines Notification (reference EL(22)A/05), Atnahs Pharma UK Limited have informed us that the Patient Information Leaflets (PILs) in the above batches are missing information

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-atnahs-pharma-uk-limited-naprosyn-tablets-all-strengths-naprosyn-ec-500mg-gastro-resistant-tablets-el-22-a-slash-09?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=bf8465ff-1733-4206-8118-29be77b0cde5&utm_content=immediately

Pip code

Product description

Supplier / Livery

Batch Numbers

0183459

NAPROSYN EC TAB 500MG (56)

ATNAHS PHARMA UK LIMITED

E0596E1

E0601E1

E0601E4

E0615E1

E0622E1

E0623E1

E0626E1

E0627E1

E0628E1

E0628E2

E0632E3

E0633E2

E0634E3

E0635E2

E0636E1

E0637E1

E0640E2

E0656E1

E0657E1

E0658E1

E0665E1

E0666E1

2434694

NAPROSYN TAB 250MG (56)

ATNAHS PHARMA UK LIMITED

E0098E5

E0098E6

E0102E1

E0102E2

E0103E1

E0174E2

E0183E1

E0186E2

E0187E1

E0188E1

E0188E4

E0189E2

E0190E1

E0191E1

2200301

NAPROSYN TAB 500MG (56)

ATNAHS PHARMA UK LIMITED

E0962E1

E0963E1

E0964E1

E0965E2

E0972E1

E0973E1

E0974E1

E0975E1

 

 

This is a caution in use only we are not accepting stock returns.

 

Further Information

For medical information queries or stock control queries, please contact: info@pharmanovia.com

 

If you have any questions, then please contact your local Service Centre Customer Services team.

 

SUB-TYPE:

Latest news from UKHSA: Living with Covid announcement

 

England only:

Following the Prime Minister’s announcement on 21 February that free mass testing will end from 1 April, this means that the Pharmacy Collect service will end on 31 March. UKHSA will work with its distributors, NHSEI and the PSNC on a smooth transition to the end of the service.

 

UKHSA continues to have good stock levels and will manage these to provide flexibility in future. Ahead of the end of free universal testing in England, it will be necessary for UKHSA to cap the number of tests distributed each day to manage demand. Given that advice to test has and continues to reduce, the Government urges people only to order what they need.

 

We will be in touch with pharmacy contractors with details such as final claims, test kits and orders.

 

Information from Alliance Healthcare:

UK & NI:
Alliance Healthcare continue to work with the UKHSA on the distribution of lateral flow tests to support the Pharmacy Collect scheme.

 

For latest PIP codes please visit myahportal.co.uk

 

SUB-TYPE:

Belfast service update

 

Due to the recent severe weather conditions across the UK, we are experiencing some disruption to the delivery of centrally stocked products due to ferry cancellations and subsequent delays at ports

 

We anticipate this to be fully resolved by Wednesday afternoon (23 February). Please do not re-order.

 

Please contact Customer Service should you need any support.  

 

We apologise for the inconvenience this may cause and appreciate your understanding.

SUB-TYPE:

Prescription Validation Service now available on the myahportal

 

Alliance Healthcare is delighted to announce the launch of a new innovative and customer friendly functionality on the Alliance Healthcare portal, www.myahportal.co.uk as of 21 February 2022

 

This new functionality allows our customers to submit their Prescription Validation orders more efficiently, and allows them to check the status of their order via the portal. This functionality will be available for customers to place and check orders 24/7.

 

This new innovation provides pharmacies with an alternative way to send an anonymised Prescription to Alliance Healthcare for validation and supply of any item subject to Prescription Validation (PVS).

 

 

Taking advantage of this new service means our accounts will benefit through                                             

- A simplified supply optimisation process for PVS - making it easier to do business with us

- Access to order progress updates so they can track the order via the myahportal

- Receipt of the required stock quicker - due to this advanced technology

- Modernisation of the process - no need to rely on fax technology

- Efficiencies to their business – another feature in our one stop shop offering provided by myahportal  

 

To help assist our accounts with this new service, we have produced a short video on how to use the new portal functionality which can be accessed here

 

For further information or assistance with this new functionality, please contact the Customer Portal Team on 0330 100 0448 – option 8 or email CustomerPortal@alliance-healthcare.co.uk with ‘PVS’ in the title of your email.

SUB-TYPE:

Service Update - 21st February 2022

 

At lunchtime today (Monday 21 February) we encountered an issue which prevented us receiving transmitted orders between 12:26 and 15:24.  

 

Our teams, along with external support, worked at speed to resolve this. The root cause was identified and it was fully rectified by 15:24.

 

Any orders placed via AH Direct (www.myahportal.co.uk) and by phone via Customer Service were unaffected.

 

Thank you for your understanding. Please check the order response on your system before re-ordering. 

 

Should you require any urgent items, please contact our Customer Service team for support.

SUB-TYPE:

Message from Marie Evans following Storm Eunice

 

Earlier today (18 February 2022), one of our vans in the Croydon area was hit by a falling tree as a result of Storm Eunice. You may have seen this incident feature on news broadcasts and social media recently. We wanted to share the news that thankfully our driver is unharmed and is home safely.
 
Please click here to read a message from Marie Evans, Managing Director.

SUB-TYPE: COMPANY-LED RECALL

Company Led Recall - Alimentum and Elecare

Abbott Nutritional Ltd is recalling as a precautionary measure.

 

MHRA drug alert link: N/A

 

Pip code

Product

Supplier

Affected Batches

4146916

ALIMENTUM POWDER 400G

ABBOTT NUTRITIONAL

ALL STOCK

4139390

ELECARE 400G POWDER

ABBOTT NUTRITIONAL

ALL STOCK

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

 

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

 

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

Class 2 Recall - Fluorouracil Injection, 50 mg/ml, solution for injection (2500mg/50ml vial)

Medac GmbH (t/a medac Pharma LLP) are recalling certain product batches as a precautionary measure due to visual detection of glass lamellae particles during an ongoing stability study.

 

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-medac-gmbh-t-slash-a-medac-pharma-llp-fluorouracil-injection-50-mg-slash-ml-solution-for-injection-2500mg-slash-50ml-vial-el-22-a-08?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=72e19d5c-b6d8-4bd5-9cd1-ac0ab189f3d0&utm_content=immediately

 

Pip code

Product Description

Supplier

Batch Numbers

1208768

FLUOROURACIL INJECTION, 50 MG/ML, SOLUTION FOR INJECTION (2500MG/50ML VIAL)

MEDAC GMBH (T/A MEDAC PHARMA LLP)

L200779AA

D210130A

E210144AA

 

Further Information

 

For more information, medical or supply enquiries, please contact Medac Pharma LLP by email to info@medacpharma.co.uk or telephone 01786 458086

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

 

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

SUB-TYPE:

Severe weather: significant service disruption across some of the network

 

Due to the severe weather across the UK, we are doing all that we can to safely continue our service. Safety remains our priority and we appreciate your understanding and cooperation during this challenging time. 


In some areas there may be some service disruption caused by road closures, access challenges and safety measures within the operation when loading and unloading deliveries. 

 

Impacted customers are being contacted and are advised not to -reorder. Anything that is not received this afternoon will be delivered in the next scheduled delivery where possible. 

 

Our emergency order service remains in place where required. 

 

Customers serviced by our Letchworth, Chessington and Croydon Service Centres may experience significant service disruption with PM deliveries today. Other impacted areas include Aberdeen, Dundee, Bristol and Cornwall. 

 

We apologise for the inconvenient this may cause and appreciate your understanding.

SUB-TYPE: CLASS 2 RECALL

Class 2 Recall - Efudix 5% W/W Cream (2 X 20g) Pack

Uni Health Distribution is aware of a potential issue where the leaflet contained within Efudix 5% w/w cream (2 x 20g) pack, batch 80193439/B may be incorrect.

 

MHRA drug alert link:

https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-uni-health-distribution-efudix-5-percent-w-slash-w-cream-el-22-a-07?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=17cc5756-8170-4e39-ac3b-145bbec7c060&utm_content=immediately

 

Pip code

Product Description

Supplier

Batch Numbers

ALLIANCE DO NOT STOCK

EFUDIX 5% W/W CREAM (2 X 20G) PACK

UNI HEALTH DISTRIBUTION

80193439/B

Alliance do not stock the above product so we will not be accepting Customer returns on this recall.

 

Further Information

 

For more information, please contact or email Margaret Fairney margaret@ennogen.com

 

For medical information queries, please contact or email Margaret Fairney margaret@ennogen.com

 

For supply queries, please contact Davide Rinaldi purchasing@ennogen.com

 

If you have any questions, then please contact your local Service Centre Customer Services team.